The 22nd Bio€quity Europe
16-18 May, 2022
Milan, Italy
Âé¶¹ÆÆ½â°æ will attend the 22nd Bio€quity Europe, the Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs.
Âé¶¹ÆÆ½â°æâ€™s team will reconnect with investors and partners to accelerate the clinical development of its lead compound Vonafexor focused on kidney and liver diseases.
Jacky Vonderscher will also present “VONAFEXOR, a fibrolytic and anti-inflammatory for the treatment of kidney and liver diseases� in the Hot Topics Track #1 session, 16:30 pm -16:42 pm, May 17